S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Biotech Slump and Semiconductor Gains Shift Market Sentiment

A sharp 19% decline in Syndax Pharmaceuticals shares dominated after-hours trading Monday after the company reported that its experimental idiopathic pulmonary fibrosis treatment failed to meet primary endpoints in a Phase 2 trial. The biotechnology firm's setback stood in contrast to positive momentum across the semiconductor equipment sector.

Biotech Slump and Semiconductor Gains Shift Market Sentiment

Teradyne signaled confidence in the chip industry by committing $300 million to a strategic partnership with FormFactor. The capital injection, aimed at advancing semiconductor testing technologies, pushed FormFactor shares up 3.6% to $134.90. The collaboration highlights ongoing efforts to refine high-end manufacturing processes.

Navitas Semiconductor also captured investor attention following the launch of a specialized power-delivery board tailored for Nvidia infrastructure. Shares of the company rose 4% to $10.39, reflecting market optimism regarding the hardware ecosystem supporting artificial intelligence development.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!